Please see below all current skin cancer clinical trials of the Central Coast Cancer Centre.
Name: SGNLV-005
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for unresectable locally advanced metastatic
solid tumours.
Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Melanoma
More information about SGNLV-005
Name: c-POST
A randomized, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma.
Principal Investigator: Dr Craig Kukard
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Skin Cancer
More information about c-POST
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials